| abstract |
A treatment and/or prevention agent for inflammatory bowel disease comprising a hydroxamic acid compound of formula (I) <CHEM> wherein R<1> is hydrogen, C1-8 alkyl or C1-8 alkyl substituted by -OR<2>, R<2> is hydrogen, C1-8 alkyl, benzyl, or C1-8 alkyl substituted by C1-8 alkoxy; or a pharmaceutical acceptable salt thereof as active ingredient. |